Clarkson Plc (CKN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the analyst to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description - A detailed description of the company’s operations and business divisions.
- Corporate strategy - Analyst’s summarization of the company’s business strategy.
- SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives’ employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Clarkson Plc (Clarkson) is a provider of shipping services. It provides ship broking services to ship owners and charterers. The company offers broking services for dry cargo, tankers, containers, gas, liquefied natural gas (LNG) and offshore. Clarkson also offers investment banking services, project finance and structured asset finance solutions. It provides support service such as port and agency, forwarding and logistics, tools and supplies, and stevedoring and warehousing. The company also offers research and information services to the shipping sector worldwide. It has operations in Europe, the Middle East, and Africa (EMEA), Asia-Pacific, and the Americas. Clarkson is headquartered in London, England, the UK.Clarkson Plc Key Recent Developments
- May 12, 2026: Avangrid Partners with Clarkson to Advance Grid Research
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
- Almac Diagnostic Services Ltd Company Overview
- Almac Diagnostic Services Ltd Company Snapshot
- Almac Diagnostic Services Ltd Pipeline Products and Ongoing Clinical Trials Overview
- Almac Diagnostic Services Ltd - Pipeline Analysis Overview
- Almac Diagnostic Services Ltd - Key Facts
- Almac Diagnostic Services Ltd - Major Products and Services
- Almac Diagnostic Services Ltd Pipeline Products by Development Stage
- Almac Diagnostic Services Ltd Pipeline Products Overview
- 2-Gene qPCR LDT
- 2-Gene qPCR LDT Product Overview
- ALM AADx Assay
- ALM AADx Assay Product Overview
- Almac EMT Assay
- Almac EMT Assay Product Overview
- Angiogenesis Subtype Diagnostic Assay
- Angiogenesis Subtype Diagnostic Assay Product Overview
- Companion Diagnostic Assay - Kidney Disease
- Companion Diagnostic Assay - Kidney Disease Product Overview
- Companion Diagnostic Assay - Non-Alcoholic Steatohepatitis
- Companion Diagnostic Assay - Non-Alcoholic Steatohepatitis Product Overview
- Companion Diagnostic Assay - Respiratory Disease
- Companion Diagnostic Assay - Respiratory Disease Product Overview
- DNA Damage Response Deficiency Assay - Breast Cancer
- DNA Damage Response Deficiency Assay - Breast Cancer Product Overview
- DNA Damage Response Deficiency Assay - Colorectal Cancer
- DNA Damage Response Deficiency Assay - Colorectal Cancer Product Overview
- DNA Damage Response Deficiency Assay - Esophageal Cancer
- DNA Damage Response Deficiency Assay - Esophageal Cancer Product Overview
- DNA Damage Response Deficiency Assay - Ovarian Cancer
- DNA Damage Response Deficiency Assay - Ovarian Cancer Product Overview
- NanoStrings’s nCounter Dx Analysis System With FLEX - CDx
- NanoStrings’s nCounter Dx Analysis System With FLEX - CDx Product Overview
- Next-Generation Sequencing Based Companion Diagnostic Assay
- Next-Generation Sequencing Based Companion Diagnostic Assay Product Overview
- Ovarian DSA
- Ovarian DSA Product Overview
- Pan-Cancer Companion Diagnostic Assay
- Pan-Cancer Companion Diagnostic Assay Product Overview
- Predictive Assay - Immuno-oncology
- Predictive Assay - Immuno-oncology Product Overview
- Prognostic Test - Early Stage Lung Cancer
- Prognostic Test - Early Stage Lung Cancer Product Overview
- Prognostic Test - NSCLC
- Prognostic Test - NSCLC Product Overview
- Prostate Cancer Metastatic Assay
- Prostate Cancer Metastatic Assay Product Overview
- RSPO3 CLIA Assay
- RSPO3 CLIA Assay Product Overview
- Almac Diagnostic Services Ltd - Key Competitors
- Almac Diagnostic Services Ltd - Key Employees
- Almac Diagnostic Services Ltd - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Almac Diagnostic Services Ltd, Recent Developments
- Jul 02, 2026: Almac Diagnostic Services Awarded Olink Certified Service Provider Status, Expanding Proteomics Capabilities for Biopharma Clients
- Jun 02, 2026: Almac Diagnostic Services Expands NGS Capabilities for Clinical Trial Research
- May 01, 2025: Almac Diagnostic Services launches PNPLA3 Genotyping Kit for Liver Disease Research
- Mar 26, 2025: Almac Diagnostic Services Adds Single Cell Sequencing to its Lab Services to Further Enable Biopharma Clients Research Needs
- Dec 08, 2021: Almac Diagnostic Services claraT report assists researchers in uncovering new oncology findings
- Sep 26, 2019: Almac’s unique gene expression report enables cancer researchers to discover exciting new insights
- Jun 05, 2019: Almac Group announces CE mark of diagnostic assay to support Turning Point Therapeutics’ pivotal TRIDENT-1 clinical trial
- May 06, 2019: Turning Point Therapeutics and Almac Diagnostic Services announce approval of an Investigational Device Exemption for the Companion Diagnostic Assay to the Registrational TRIDENT-1 Clinical Study
- Mar 27, 2019: Almac Group launches upgraded version of claraT - a unique, software-driven gene expression report
- Oct 19, 2018: Almac Group launches claraT - A unique, software-driven gene expression report
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- Almac Diagnostic Services Ltd Pipeline Products and Ongoing Clinical Trials Overview
- Almac Diagnostic Services Ltd Pipeline Products by Equipment Type
- Almac Diagnostic Services Ltd Pipeline Products by Indication
- Almac Diagnostic Services Ltd, Key Facts
- Almac Diagnostic Services Ltd, Major Products and Services
- Almac Diagnostic Services Ltd Number of Pipeline Products by Development Stage
- Almac Diagnostic Services Ltd Pipeline Products Summary by Development Stage
- 2-Gene qPCR LDT - Product Status
- 2-Gene qPCR LDT - Product Description
- ALM AADx Assay - Product Status
- ALM AADx Assay - Product Description
- Almac EMT Assay - Product Status
- Almac EMT Assay - Product Description
- Angiogenesis Subtype Diagnostic Assay - Product Status
- Angiogenesis Subtype Diagnostic Assay - Product Description
- Companion Diagnostic Assay - Kidney Disease - Product Status
- Companion Diagnostic Assay - Kidney Disease - Product Description
- Companion Diagnostic Assay - Non-Alcoholic Steatohepatitis - Product Status
- Companion Diagnostic Assay - Non-Alcoholic Steatohepatitis - Product Description
- Companion Diagnostic Assay - Respiratory Disease - Product Status
- Companion Diagnostic Assay - Respiratory Disease - Product Description
- DNA Damage Response Deficiency Assay - Breast Cancer - Product Status
- DNA Damage Response Deficiency Assay - Breast Cancer - Product Description
- DNA Damage Response Deficiency Assay - Colorectal Cancer - Product Status
- DNA Damage Response Deficiency Assay - Colorectal Cancer - Product Description
- DNA Damage Response Deficiency Assay - Esophageal Cancer - Product Status
- DNA Damage Response Deficiency Assay - Esophageal Cancer - Product Description
- DNA Damage Response Deficiency Assay - Ovarian Cancer - Product Status
- DNA Damage Response Deficiency Assay - Ovarian Cancer - Product Description
- NanoStrings’s nCounter Dx Analysis System With FLEX - CDx - Product Status
- NanoStrings’s nCounter Dx Analysis System With FLEX - CDx - Product Description
- Next-Generation Sequencing Based Companion Diagnostic Assay - Product Status
- Next-Generation Sequencing Based Companion Diagnostic Assay - Product Description
- Ovarian DSA - Product Status
- Ovarian DSA - Product Description
- Pan-Cancer Companion Diagnostic Assay - Product Status
- Pan-Cancer Companion Diagnostic Assay - Product Description
- Predictive Assay - Immuno-oncology - Product Status
- Predictive Assay - Immuno-oncology - Product Description
- Prognostic Test - Early Stage Lung Cancer - Product Status
- Prognostic Test - Early Stage Lung Cancer - Product Description
- Prognostic Test - NSCLC - Product Status
- Prognostic Test - NSCLC - Product Description
- Prostate Cancer Metastatic Assay - Product Status
- Prostate Cancer Metastatic Assay - Product Description
- RSPO3 CLIA Assay - Product Status
- RSPO3 CLIA Assay - Product Description
- Almac Diagnostic Services Ltd, Key Employees
- Almac Diagnostic Services Ltd, Other Locations
- Glossary
- Almac Diagnostic Services Ltd Pipeline Products by Equipment Type
- Almac Diagnostic Services Ltd Pipeline Products by Development Stage
